REQUEST A DEMO
Total
USD $0.00
Search more companies

Oz-sel Ecza Depolari Ticaret Ve Pazarlama A.S. (Turkiye)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Oz-sel Ecza Depolari Ticaret Ve Pazarlama Anonim Sirketi Profile Updated: November 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Özsel Ecza Depoları Tic ve Paz A.Ş is a Turkish company, headquartered in Umraniye. It is a supplier of public medicine in Turkey, serving multinational pharmaceutical companies. The company claims to have a strong staff to respond to purchasing requests from the health sector across Turkey and has expanded its activity network to various branches across the country.

Headquarters
D:1 No:6 Serifali Mahallesi Soylesi Sokak Umraniye
Istanbul; Marmara; Postal Code: 34775

Contact Details: Purchase the Oz-sel Ecza Depolari Ticaret Ve Pazarlama A.S. report to view the information.

Website: http://www.ozsel.com

Basic Information
Total Employees:
Purchase the Oz-sel Ecza Depolari Ticaret Ve Pazarlama A.S. report to view the information.
Outstanding Shares:
Purchase the Oz-sel Ecza Depolari Ticaret Ve Pazarlama A.S. report to view the information.
Incorporation Date:
March 03, 1977
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Oz-sel Ecza Depolari Ticaret Ve Pazarlama A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
15.25%
Total operating revenue
15.25%
Operating profit (EBIT)
103.18%
Net Profit (Loss) for the Period
106.06%
Total assets
12.26%
Total equity
46.3%
Operating Profit Margin (ROS)
8.37%
Net Profit Margin
8.53%
Return on Equity (ROE)
12.88%
Debt to Equity Ratio
-13.36%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?